Ivens IA - Search Results

1

Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies.

Ponce R, Abad L, Amaravadi L, Gelzleichter T, Gore E, Green J, Gupta S, Herzyk D, Hurst C, Ivens IA, Kawabata T, Maier C, Mounho B, Rup B, Shankar G, Smith H, Thomas P, Wierda D. Ponce R, et al. Among authors: ivens ia. Regul Toxicol Pharmacol. 2009 Jul;54(2):164-82. doi: 10.1016/j.yrtph.2009.03.012. Epub 2009 Apr 2. Regul Toxicol Pharmacol. 2009. PMID: 19345250

2

Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations.

Vahle JL, Finch GL, Heidel SM, Hovland DN Jr, Ivens I, Parker S, Ponce RA, Sachs C, Steigerwalt R, Short B, Todd MD. Vahle JL, et al. Toxicol Pathol. 2010 Jun;38(4):522-53. doi: 10.1177/0192623310368984. Epub 2010 May 14. Toxicol Pathol. 2010. PMID: 20472697 Review.

3

PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development.

Ivens IA, Achanzar W, Baumann A, Brändli-Baiocco A, Cavagnaro J, Dempster M, Depelchin BO, Rovira AR, Dill-Morton L, Lane JH, Reipert BM, Salcedo T, Schweighardt B, Tsuruda LS, Turecek PL, Sims J. Ivens IA, et al. Toxicol Pathol. 2015 Oct;43(7):959-83. doi: 10.1177/0192623315591171. Epub 2015 Aug 3. Toxicol Pathol. 2015. PMID: 26239651 Review.

4

Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG.

Ivens IA, Banczyk D, Gutberlet K, Jackman S, Vauléon S, Frisk AL. Ivens IA, et al. Toxicol Pathol. 2019 Jul;47(5):585-597. doi: 10.1177/0192623319852300. Epub 2019 May 27. Toxicol Pathol. 2019. PMID: 31132933 Free PMC article.

5

PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers.

Ivens IA, Baumann A, McDonald TA, Humphries TJ, Michaels LA, Mathew P. Ivens IA, et al. Haemophilia. 2013 Jan;19(1):11-20. doi: 10.1111/j.1365-2516.2012.02931.x. Epub 2012 Aug 23. Haemophilia. 2013. PMID: 22913770 Review.

6

PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs.

Turecek PL, Bossard MJ, Schoetens F, Ivens IA. Turecek PL, et al. Among authors: ivens ia. J Pharm Sci. 2016 Feb;105(2):460-475. doi: 10.1016/j.xphs.2015.11.015. J Pharm Sci. 2016. PMID: 26869412 Review.

7

Subacute oral toxicity of tetraethylene glycol and ethylene glycol administered to Wistar rats.

Schladt L, Ivens I, Karbe E, Rühl-Fehlert C, Bomhard E. Schladt L, et al. Exp Toxicol Pathol. 1998 Jun;50(3):257-65. doi: 10.1016/S0940-2993(98)80096-1. Exp Toxicol Pathol. 1998. PMID: 9681658

8

Toxicity of 2,3,7,8-tetrabromodibenzo-p-dioxin in rats after single oral administration.

Ivens IA, Löser E, Rinke M, Schmidt U, Neupert M. Ivens IA, et al. Toxicology. 1992;73(1):53-69. doi: 10.1016/0300-483x(92)90170-j. Toxicology. 1992. PMID: 1589880

9

Subchronic toxicity of 2,3,7,8-tetrabromodibenzo-p-dioxin in rats.

Ivens IA, Löser E, Rinke M, Schmidt U, Mohr U. Ivens IA, et al. Toxicology. 1993 Oct 25;83(1-3):181-201. doi: 10.1016/0300-483x(93)90101-w. Toxicology. 1993. PMID: 8248944

10

Subcutaneous administration of biotherapeutics: current experience in animal models.

McDonald TA, Zepeda ML, Tomlinson MJ, Bee WH, Ivens IA. McDonald TA, et al. Among authors: ivens ia. Curr Opin Mol Ther. 2010 Aug;12(4):461-70. Curr Opin Mol Ther. 2010. PMID: 20677097 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters